Plasma levels of MCP-1 predict cardiovascular events in patients with stable CAD and persistent inflammation, defined as C-reactive protein (CRP) levels above 2 mg/L as measured by high-sensitivity methods [33]. Here, CCL2 is linked to coronary artery disorder.